Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides : Phase Behavior and Antimicrobial Effect

The number of antibiotic-resistant bacteria is increasing worldwide, and the demand for novel antimicrobials is constantly growing. Antimicrobial peptides (AMPs) could be an important part of future treatment strategies of various bacterial infection diseases. However, AMPs have relatively low stabi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 32(2016), 17 vom: 03. Mai, Seite 4217-28
1. Verfasser: Boge, Lukas (VerfasserIn)
Weitere Verfasser: Bysell, Helena, Ringstad, Lovisa, Wennman, David, Umerska, Anita, Cassisa, Viviane, Eriksson, Jonny, Joly-Guillou, Marie-Laure, Edwards, Katarina, Andersson, Martin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antimicrobial Cationic Peptides Drug Carriers Lipids
LEADER 01000naa a22002652 4500
001 NLM258965932
003 DE-627
005 20231224190148.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.6b00338  |2 doi 
028 5 2 |a pubmed24n0863.xml 
035 |a (DE-627)NLM258965932 
035 |a (NLM)27033359 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Boge, Lukas  |e verfasserin  |4 aut 
245 1 0 |a Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides  |b Phase Behavior and Antimicrobial Effect 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 29.05.2018 
500 |a Date Revised 29.05.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a The number of antibiotic-resistant bacteria is increasing worldwide, and the demand for novel antimicrobials is constantly growing. Antimicrobial peptides (AMPs) could be an important part of future treatment strategies of various bacterial infection diseases. However, AMPs have relatively low stability, because of proteolytic and chemical degradation. As a consequence, carrier systems protecting the AMPs are greatly needed, to achieve efficient treatments. In addition, the carrier system also must administrate the peptide in a controlled manner to match the therapeutic dose window. In this work, lyotropic liquid crystalline (LC) structures consisting of cubic glycerol monooleate/water and hexagonal glycerol monooleate/oleic acid/water have been examined as carriers for AMPs. These LC structures have the capability of solubilizing both hydrophilic and hydrophobic substances, as well as being biocompatible and biodegradable. Both bulk gels and discrete dispersed structures (i.e., cubosomes and hexosomes) have been studied. Three AMPs have been investigated with respect to phase stability of the LC structures and antimicrobial effect: AP114, DPK-060, and LL-37. Characterization of the LC structures was performed using small-angle X-ray scattering (SAXS), dynamic light scattering, ζ-potential, and cryogenic transmission electron microscopy (Cryo-TEM) and peptide loading efficacy by ultra performance liquid chromatography. The antimicrobial effect of the LCNPs was investigated in vitro using minimum inhibitory concentration (MIC) and time-kill assay. The most hydrophobic peptide (AP114) was shown to induce an increase in negative curvature of the cubic LC system. The most polar peptide (DPK-060) induced a decrease in negative curvature while LL-37 did not change the LC phase at all. The hexagonal LC phase was not affected by any of the AMPs. Moreover, cubosomes loaded with peptides AP114 and DPK-060 showed preserved antimicrobial activity, whereas particles loaded with peptide LL-37 displayed a loss in its broad-spectrum bactericidal properties. AMP-loaded hexosomes showed a reduction in antimicrobial activity 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antimicrobial Cationic Peptides  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Lipids  |2 NLM 
700 1 |a Bysell, Helena  |e verfasserin  |4 aut 
700 1 |a Ringstad, Lovisa  |e verfasserin  |4 aut 
700 1 |a Wennman, David  |e verfasserin  |4 aut 
700 1 |a Umerska, Anita  |e verfasserin  |4 aut 
700 1 |a Cassisa, Viviane  |e verfasserin  |4 aut 
700 1 |a Eriksson, Jonny  |e verfasserin  |4 aut 
700 1 |a Joly-Guillou, Marie-Laure  |e verfasserin  |4 aut 
700 1 |a Edwards, Katarina  |e verfasserin  |4 aut 
700 1 |a Andersson, Martin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 32(2016), 17 vom: 03. Mai, Seite 4217-28  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:32  |g year:2016  |g number:17  |g day:03  |g month:05  |g pages:4217-28 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.6b00338  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 32  |j 2016  |e 17  |b 03  |c 05  |h 4217-28